We strive to contribute to groundbreaking therapies with our screenable, physiologically relevant 3D human disease models. By combining technological strengths and expertise, we establish strong drug development partnerships with and offer services to global pharmaceutical companies to develop innovative therapies to target untreatable diseases. For more information, visit: www.mimetas.com.
View Top Employees from MIMETAS| Website | https://mimetas.com |
| Revenue | $5 million |
| Funding | $6.8 million |
| Employees | 125 (125 on RocketReach) |
| Founded | 2013 |
| Address | 7 5 De Limes, Oegstgeest, South Holland, NL |
| Phone | +31 85 888 3161 |
| Technologies |
JavaScript,
HTML,
PHP
+22 more
(view full list)
|
| Industry | Biotechnology Research, Business Services General, 3D Technology, Organ-On-A-Chip, Business Services, Hardware, Microfluidics, Software, 3D cell culture, Health Care, Cell-Based Assays, Information Technology, Toxicology, Tissue Models, Disease Models |
| Web Rank | 2 Million |
| Keywords | Pharmaceutical Services, Innovative Therapies, Drug Development And Manufacturing, Preclinical Research |
| Competitors | AB Science, CN Bio, Organovo Holdings, Inc., Systematica, TARA Biosystems |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies |
Looking for a particular MIMETAS employee's phone or email?
MIMETAS Questions
The MIMETAS annual revenue was $5 million in 2024.
Paul Vulto is the Chief Executive Officer, board member, founder of MIMETAS.
125 people are employed at MIMETAS.
MIMETAS is based in Oegstgeest, South Holland.
The NAICS codes for MIMETAS are [541, 54, 541713, 54171, 5417].
The SIC codes for MIMETAS are [873, 87].
Top MIMETAS Employees
-
5+4
-
25+
-
14
-
2
-
1
-
View
Mieke Doornbos
Vice President Sales and Marketing at MIMETAS
Leiden, South Holland, Netherlands51 -
2
-
2
-
21
-
11
Related Companies
